Artivion
Update in progressAORT (NYSE)
- Company RatingNeutralCompany RatingCombines sentiment and sustainability signals into an overall assessment of the company.Great · Good · Neutral · At Risk · Poor
- SectorHealthcare
- IndustryMedical Devices
Artivion, Inc. develops, manufactures, and distributes medical devices and implantable tissues worldwide. Its portfolio includes On-X heart valves, a range of stent grafts and vascular products, arterial and vascular grafts, surgical sealants, tissue patches, and preservation or decellularization services. Products are marketed mainly to hospitals via a direct sales force. Formerly CryoLife, renamed in 2022. Based in Kennesaw, Georgia.
Company score
- Sentiment
- 0.24
- SentimentMeasures the overall tone of recent coverage and discussion about the company.−10 negative · 0 neutral · +10 positive
- Environment
- 0.00
- EnvironmentAssesses the company’s environmental impact, risks, and sustainability practices.−10 negative · 0 neutral · +10 positive
- Social
- 0.13
- Governance
- -0.19
- GovernanceAssesses leadership, accountability, transparency, and business ethics.−10 negative · 0 neutral · +10 positive
- Sustainability
- 0.00
- SustainabilityCombines environmental, social, and governance signals into an overall sustainability score.−10 negative · 0 neutral · +10 positive
- Impact Score
- 0.12
- Impact ScoreCombines sentiment and sustainability performance into an assessment of the company’s overall impact.−10 negative · 0 neutral · +10 positive
Company
- MarketNYSE (NYQ)
- LocationUnited States
- CEOMr. James Patrick Mackin
- Founded1984
- Employees1,800
- Websiteartivion.com
Identifiers
- ISINUS2289031005
- FIGIBBG000BMLVJ6
- LEI549300YTKV8DMSMG6K81
- CUSIP228903100
- CIK0000784199